![Kenneth Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hoberman
Direttore operativo presso
STEMLINE THERAPEUTICS, INC.
Patrimonio netto: 19 M $ in data 30/09/2026
Profilo
Mr. Kenneth Hoberman is an Independent Director at Nuvectis Pharma, Inc., an Independent Director at TG Therapeutics, Inc. and a Chief Operating Officer at Stemline Therapeutics, Inc. He is on the Board of Directors at Lirum Therapeutics, Inc., Nuvectis Pharma, Inc. and TG Therapeutics, Inc. Mr. Hoberman was previously employed as a Vice President-Corporate & Business Development by Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from Boston University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 279.653 ( 0,18% ) | 16 M $ | 30/09/2026 | |
| 11/06/2026 | 168.140 ( 0,52% ) | 4 M $ | 30/09/2026 |
Posizioni attive di Kenneth Hoberman
| Società | Posizione | Inizio |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Direttore operativo | 01/01/2013 |
| TG THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 15/12/2014 |
| NUVECTIS PHARMA, INC. | Direttore/Membro del Consiglio | 01/07/2021 |
| LIRUM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/11/2021 |
Precedenti posizioni note di Kenneth Hoberman
| Società | Posizione | Fine |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 01/01/2012 |
Formazione di Kenneth Hoberman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that focuses on the treatment of debilitating diseases | Commercial Services |
